Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05752084

Bilirubin Increases the Risk of NIs in Cirrhotic Patients

Conditions: Nosocomial Infection

Sex: All

Ages: 18 Years – 75 Years

Enrollment: 250

Sponsor: Tanta University

Location: Egypt

Summary

Nosocomial infection (NIs) is a major challenge in healthcare facilities and has been associated with prolonged hospital stay as well as increased morbidity and mortality.This research aimed to estimate the impact of acute decompensation (AD) consequences on the successive risk of nosocomial infections (NIs) and the go after outcome.

Eligibility Criteria

Inclusion Criteria:cirrhotic patients both sexExclusion Criteria:pregnancylactationHCC

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05752084). StuddyBuddy aggregates publicly available trial information.